Lymphocytoma Cutis - A Case Report
Main Article Content
Keywords
pseudolymphoma, lymphocytoma, hyperplastic lymphoid reaction
Abstract
Without tissue biopsy and holistic review of presentation, histology, and immunohistochemistry, lymphocytoma cutis (LC) can often be misdiagnosed as other benign conditions or malignant pathologies such as cutaneous B cell lymphoma (CBCL). A 36-year-old female presented with a two-year history of a progressive indurated, edematous plaque in the preauricular area. At presentation, the patient also had labs significant for thrombocytopenia and eosinophilia. Original treatment with topical steroids did not lead to clinical improvement of the lesions. Punch biopsy revealed reactive lymphoid hyperplasia with polyclonal lymphoid infiltrates of small lymphocytes, histiocytes, eosinophils, and plasma cells. Diagnosis of LC was made and our patient was treated with serial 5 mg intralesional triamcinolone injections. Clinical improvement was seen beginning at 2 months. Diagnosing LC can be particularly difficult as the clinical presentation is ubiquitous and can resemble several other conditions such as CBCL, cutaneous lupus erythematosus, sarcoid, or hypersensitivity reactions. Recognition of the typical histologic findings of top-heavy dermal mixed-cellular infiltrates along with polyclonal kappa and lambda hybridization on immunohistochemistry is often essential in arriving at the correct diagnosis. Following diagnosis of LC, long-term surveillance is recommended as malignant transformation is a possibility.
References
2. van Vloten W, Willemze R. The many faces of lymphocytoma cutis. Journal of the European Academy of Dermatology and Venereology. 2003;17(1):3-6. doi:10.1046/j.1468-3083.2003.00482.x
3. Villalobos‐Ayala RA, Espinoza‐Gurrola AA, Guevara‐Gutiérrez E, et al. Lymphocytoma cutis (cutaneous B‐cell pseudolymphoma): study of 102 cases with emphasis on the histological characteristics and immunohistochemistry of the miliarial type. Int J Dermatol. 2022;61(3):316-323. doi:10.1111/ijd.15909
4. Self SJ. Disseminated Lymphocytoma Cutis. Arch Dermatol. 1969;100(4):459. doi:10.1001/archderm.1969.01610280077015
5. Oliveira EVL de, Badiale GB, Moraes MMFS. Lymphocytoma cutis - case report. An Bras Dermatol. 2013;88(6 suppl 1):128-131. doi:10.1590/abd1806-4841.20132320
6. O’Neill J, Fien S, Zeitouni NC. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report. J Drugs Dermatol. 2010;9(6):688-689.
7. Rosa WSC, Girão RJS, Carvalho IMS, Vargas LMML. Lymphocytoma cutis on the inguinal region: report of a rare case of benign lymphoproliferative disorder. An Bras Dermatol. 2017;92(5 Suppl 1):98-100. doi:10.1590/abd1806-4841.20175555
8. Joseph D, Irukulla MM, Ahmed SF, Valiyaveettil D, Akram S. Radiotherapy in aggressive cutaneous pseudolymphoma: a case report and review of literature. Radiat Oncol J. 2016;34(1):76-80. doi:10.3857/roj.2016.34.1.76
9. Mitteldorf, C, Kempf, W. Cutaneous pseudolymphoma—A review on the spectrum and a proposal for a new classification. J Cutan Pathol. 2020; 47: 76– 97. https://doi.org/10.1111/cup.13532
10. Hood AF, Farmer ER. Histopathology of cutaneous lupus erythematosus. Clin Dermatol. 1985;3(3):36-48. doi:10.1016/0738-081x(85)90076-8
11. Tana C, Donatiello I, Caputo A, et al. Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis. Cells. 2021;11(1):59. Published 2021 Dec 26. doi:10.3390/cells11010059
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.